Insights On Regulatory Compliance
-
Biological Indicators - Population Assay
10/7/2022
Learn about one of the simpler incoming tests end users can perform to verify the biological indicators they receive.
-
Implementing A Risk-Based Approach To Calibration
2/20/2024
Discover why companies may benefit from a risk-based approach to calibration, utilizing information from User Requirement Specifications and other documents created during process development.
-
Managing The Challenges Of A Successful Commercial Tech Transfer
9/14/2023
View the webinar to uncover common issues that impact commercial tech transfers and hear experts share key points for building a seamless partnership between the client and outsourcing partner.
-
Streamline Early-Stage Development To Reach The Clinic Faster
7/17/2023
Early-stage development is an iterative process, continuously generating new data and insights to optimize the product based on emerging knowledge.
-
The Problems With Construction Quality In Life Sciences
11/7/2023
In the mission-critical construction industry, quality management is underperforming. Understand the importance of quality control in life sciences commissioning processes and construction programs.
-
3 Paths to Patient Centricity in Pharma
4/10/2023
Learn about the benefits of patient centricity and an enterprise-wide approach to products, processes, and partnership that focuses on the patient perspective.
-
4 Essential Components Of An Audit Management System For Life Sciences
11/15/2022
The COVID-19 pandemic has changed audits and inspections. To combat these challenges, companies need to adopt an electronic quality management system that covers every aspect of audits and inspections.
-
Developing Injectable Drug Placebo Formulations For Clinical Trials
1/9/2024
Developing a placebo for an injectable drug requires consideration of the formulation’s impact in trials, chemistry and physical details, ethical concerns, and regulatory compliance.
-
Downstream Strategies To Accelerate Preclinical Development Timelines
4/3/2024
As recombinant protein-based products accelerate toward IND, reliable process development methods are critical to meet demand. Review case studies to learn how expedited timelines can be achieved.
-
Combat Major Cell And Gene Therapy Manufacturing Regulatory Obstacles
8/8/2023
As cell and gene therapies grow in the pharmaceutical industry, drug sponsors must determine how to successfully navigate evolving regulations, study design considerations, and a lack of animal models.